Data / Medical devices / Denmark / ATSI Logistics Center ApS
ATSI Logistics Center ApS: FDA-registered device maker in GLOSTRUP Hovedstaden, Denmark, 28 510(k) clearances and 2 PMA approvals
ATSI Logistics Center ApS is registered with the FDA (registration 3013059683) in GLOSTRUP Hovedstaden, Denmark. It lists 37 device types. The FDA files 28 510(k) clearances and 2 PMA approvals under its listings, the newest dated December 21, 2017. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3013059683
- Address
- 42 Produktionsvej --, GLOSTRUP Hovedstaden, Denmark, DK-2600
- Owner or operator
- Agilent Technologies, Inc (10038794)
- Roles
- Exporter to the US
- First device listed
- November 25, 2014
- Registered through
- 2026
- Brand names listed
- 28S rRNA CISH Probe, ACIS III Tissue Micro-Array Application Software, ADVANCE HRP, AEC Substrate-Chromogen, Ready-to-Use, AEC+ High Sensitivity Substrate Chromogen, Ready-to-Use, AEC+ Substrate-Chromogen, Ready-to-Use, ALK FISH DNA Probe, Split Signal, ARK (Animal Research Kit)/HRP and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| December 21, 2017 | K170005 | FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294, Ready-to-Use (Dako Omnis) | MXZ | Substantially Equivalent | Dako Denmark A/S | accessdata.fda.gov |
| September 3, 2004 | K041627 | CYSTATIN C IMMUNOPARTICLES, CONTROL SET, CALIBRATOR | NDY | Substantially Equivalent | Dako A/S | accessdata.fda.gov |
| January 22, 2004 | K032692 | DAKOCYTOMATION BETA-2-MICROGLOBULIN KIT, CODE NO. OA 368 | JZG | Substantially Equivalent | Dako A/S | accessdata.fda.gov |
| June 21, 1999 | K991454 | MOUSE IGG1 NEGATIVE CONTROLS | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| June 21, 1999 | K991402 | DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE-CY5, CLONE UCHT1 & DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE, CLONE UCHT1 | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 22, 1998 | K980635 | DAKO MOUSE ANTI-HUMAN B-CELL, CD19/RPE-CY5, CLONE HD37 | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| June 24, 1997 | K964974 | MOUSE ANTI-HUMAN CD45, LEUCOCYTE COMMON ANTIGEN (LCA)/FITC AND CD14, MONOCYTE/RPE | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| June 14, 1996 | K960531 | MOUSE ANTI-HUMAN CD3, T-CELL/FITC & CD19, B-CELL/RPE | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| May 17, 1996 | K960887 | MOUSE ANTI-HUMAN CD4, T-CELL, HELPER/INDUCER/FITC & CD8, T-CELL, SUPPRESSOR/CYTOTOXIC/RPE | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| January 26, 1996 | K945212 | MONOCLONAL MOUSE ANTI-HUMAN T-CELL, CD4, CLONE MT310, FITC-CONJUGATED, (ANTI-CD4/FITC, MT310) RPE-CONJUGATED, (ANTI-CD4/ | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| April 20, 1995 | K931192 | DAKO RABBIT ANTI-COW S-100 POLYCLONAL ANTIBODY | DEH | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| November 21, 1994 | K944253 | MONOCLONAL MOUSE ANTI-HUMAN T-CELL, CD8, RPE-CONJUGATED, CLONE DK25 | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| November 21, 1994 | K943284 | MONOCLONAL MOUSE ANTI-HUMAN B-CELL | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| November 10, 1994 | K942797 | MONOCLONAL MOUSE ANTI-HUMAN T-CELL | GKZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 19, 1983 | K831907 | RABBIT ANTISERUM TO HUMAN IGM | DFS | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 19, 1983 | K831906 | RABBIT ANTISERUM TO HUMAN C4 | DBI | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 19, 1983 | K831904 | RABBIT ANTISERUM TO HUMAN KAPPA LIGHT | DEO | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 19, 1983 | K831903 | FLUORESCEIN CONJUGATED IMMUNOGLOBULIN | DES | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 18, 1983 | K831909 | RABBIT ANTISERUM TO HUMAN IGA | CZN | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 18, 1983 | K831908 | RABBIT ANTISERUM TO HUMAN IGG | DGK | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 18, 1983 | K831905 | RABBITT ANTISERUM TO HUMAN C3C | CZW | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| July 18, 1983 | K831902 | FLUORESCEIN CONJUGATED IMMUNOGLOBIN- | DDZ | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 29, 1981 | K812662 | IMMUNOGL. FRACT. OF RABBIT ANTIS./LAMBDA | DEH | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 29, 1981 | K812661 | IMMUNOGL. FRACT. OF RABBIT ANTIS./KAPPA | DFH | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 23, 1981 | K812495 | IMMUNOGL. FRCT. OF RABBIT ANTISER.-ALPHA | DEW | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 23, 1981 | K812489 | IMMUNOGL. FRCT. OF RABBIT ANTISER.-IGG | DEW | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 23, 1981 | K812488 | IMMUNOGL. FRCT. OF RABBIT ANTISER.-IGA | CZP | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
| September 23, 1981 | K812487 | IMMUNOGL. FRCT. OF RABBIT ANTISER.-IGM | DAO | Substantially Equivalent | Dako Corp. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| May 3, 2005 | P040005 | DAKOCYTOMATION HER2 FISH PHARMDX KIT | MVD | 14 | April 12, 2017 | accessdata.fda.gov |
| September 25, 1998 | P980018 | DAKO HERCEPTEST | MVC | 27 | September 21, 2026 | accessdata.fda.gov |
Compare with other makers
- All makers of Albumin, Fitc, Antigen, Antiserum, Control
- All makers of Kappa, Antigen, Antiserum, Control
- All makers of Complement C4, Antigen, Antiserum, Control
- All makers of Equipment, Laboratory, General Purpose, Labeled Or Promoted For A Specific Medical Use
- All makers of Iga, Fitc, Antigen, Antiserum, Control
- All makers of Research Use Only/Pathology
Updated December 21, 2017. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.